company background image
DOCM logo

DocMorris SWX:DOCM Stock Report

Last Price

CHF 35.26

Market Cap

CHF 454.7m

7D

13.5%

1Y

-6.0%

Updated

30 Oct, 2024

Data

Company Financials +

DocMorris AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for DocMorris
Historical stock prices
Current Share PriceCHF 35.26
52 Week HighCHF 101.60
52 Week LowCHF 29.74
Beta1.41
11 Month Change-5.47%
3 Month Change-20.84%
1 Year Change-6.02%
33 Year Change-89.60%
5 Year Change-63.72%
Change since IPO-77.95%

Recent News & Updates

DocMorris AG's (VTX:DOCM) Subdued P/S Might Signal An Opportunity

Oct 25
DocMorris AG's (VTX:DOCM) Subdued P/S Might Signal An Opportunity

Does DocMorris (VTX:DOCM) Have A Healthy Balance Sheet?

Sep 22
Does DocMorris (VTX:DOCM) Have A Healthy Balance Sheet?

Recent updates

DocMorris AG's (VTX:DOCM) Subdued P/S Might Signal An Opportunity

Oct 25
DocMorris AG's (VTX:DOCM) Subdued P/S Might Signal An Opportunity

Does DocMorris (VTX:DOCM) Have A Healthy Balance Sheet?

Sep 22
Does DocMorris (VTX:DOCM) Have A Healthy Balance Sheet?

Would Zur Rose Group (VTX:ROSE) Be Better Off With Less Debt?

Sep 07
Would Zur Rose Group (VTX:ROSE) Be Better Off With Less Debt?

We Think Zur Rose Group (VTX:ROSE) Has A Fair Chunk Of Debt

Dec 05
We Think Zur Rose Group (VTX:ROSE) Has A Fair Chunk Of Debt

We Think Zur Rose Group (VTX:ROSE) Has A Fair Chunk Of Debt

Aug 22
We Think Zur Rose Group (VTX:ROSE) Has A Fair Chunk Of Debt

Is Zur Rose Group (VTX:ROSE) Using Too Much Debt?

Apr 19
Is Zur Rose Group (VTX:ROSE) Using Too Much Debt?

Earnings Update: Zur Rose Group AG (VTX:ROSE) Just Reported And Analysts Are Trimming Their Forecasts

Mar 22
Earnings Update: Zur Rose Group AG (VTX:ROSE) Just Reported And Analysts Are Trimming Their Forecasts

Some Zur Rose Group AG (VTX:ROSE) Analysts Just Made A Major Cut To Next Year's Estimates

Mar 20
Some Zur Rose Group AG (VTX:ROSE) Analysts Just Made A Major Cut To Next Year's Estimates

What Kind Of Investors Own Most Of Zur Rose Group AG (VTX:ROSE)?

Feb 23
What Kind Of Investors Own Most Of Zur Rose Group AG (VTX:ROSE)?

Is Zur Rose Group's (VTX:ROSE) Share Price Gain Of 210% Well Earned?

Jan 19
Is Zur Rose Group's (VTX:ROSE) Share Price Gain Of 210% Well Earned?

Zur Rose Group AG (VTX:ROSE) Is Expected To Breakeven In The Near Future

Dec 15
Zur Rose Group AG (VTX:ROSE) Is Expected To Breakeven In The Near Future

Shareholder Returns

DOCMCH Consumer RetailingCH Market
7D13.5%-0.06%-1.4%
1Y-6.0%-18.8%12.3%

Return vs Industry: DOCM exceeded the Swiss Consumer Retailing industry which returned -17.9% over the past year.

Return vs Market: DOCM underperformed the Swiss Market which returned 14.5% over the past year.

Price Volatility

Is DOCM's price volatile compared to industry and market?
DOCM volatility
DOCM Average Weekly Movement8.8%
Consumer Retailing Industry Average Movement3.7%
Market Average Movement3.3%
10% most volatile stocks in CH Market7.1%
10% least volatile stocks in CH Market1.6%

Stable Share Price: DOCM's share price has been volatile over the past 3 months compared to the Swiss market.

Volatility Over Time: DOCM's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swiss stocks.

About the Company

FoundedEmployeesCEOWebsite
19931,453Walter Hesscorporate.docmorris.com/en

DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products. It also provides professional health care services.

DocMorris AG Fundamentals Summary

How do DocMorris's earnings and revenue compare to its market cap?
DOCM fundamental statistics
Market capCHF 454.75m
Earnings (TTM)-CHF 97.26m
Revenue (TTM)CHF 1.00b

0.5x

P/S Ratio

-4.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DOCM income statement (TTM)
RevenueCHF 1.00b
Cost of RevenueCHF 792.13m
Gross ProfitCHF 210.66m
Other ExpensesCHF 307.92m
Earnings-CHF 97.26m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Mar 13, 2025

Earnings per share (EPS)-7.54
Gross Margin21.01%
Net Profit Margin-9.70%
Debt/Equity Ratio93.8%

How did DOCM perform over the long term?

See historical performance and comparison